GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SINTX Technologies Inc (FRA:1110) » Definitions » Gross Margin %

SINTX Technologies (FRA:1110) Gross Margin % : 27.82% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is SINTX Technologies Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. SINTX Technologies's Gross Profit for the three months ended in Mar. 2024 was €0.08 Mil. SINTX Technologies's Revenue for the three months ended in Mar. 2024 was €0.28 Mil. Therefore, SINTX Technologies's Gross Margin % for the quarter that ended in Mar. 2024 was 27.82%.


The historical rank and industry rank for SINTX Technologies's Gross Margin % or its related term are showing as below:

FRA:1110' s Gross Margin % Range Over the Past 10 Years
Min: 20.03   Med: 41.05   Max: 75.19
Current: 31.35


During the past 13 years, the highest Gross Margin % of SINTX Technologies was 75.19%. The lowest was 20.03%. And the median was 41.05%.

FRA:1110's Gross Margin % is ranked worse than
78.27% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 52.77 vs FRA:1110: 31.35

SINTX Technologies had a gross margin of 27.82% for the quarter that ended in Mar. 2024 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for SINTX Technologies was 8.00% per year.


SINTX Technologies Gross Margin % Historical Data

The historical data trend for SINTX Technologies's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SINTX Technologies Gross Margin % Chart

SINTX Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.00 20.08 25.93 55.91 36.03

SINTX Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.89 55.76 30.57 23.74 27.82

Competitive Comparison of SINTX Technologies's Gross Margin %

For the Medical Devices subindustry, SINTX Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SINTX Technologies's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SINTX Technologies's Gross Margin % distribution charts can be found below:

* The bar in red indicates where SINTX Technologies's Gross Margin % falls into.



SINTX Technologies Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

SINTX Technologies's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=0.4 / 1.124
=(Revenue - Cost of Goods Sold) / Revenue
=(1.124 - 0.719) / 1.124
=36.03 %

SINTX Technologies's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=0.1 / 0.284
=(Revenue - Cost of Goods Sold) / Revenue
=(0.284 - 0.205) / 0.284
=27.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


SINTX Technologies  (FRA:1110) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

SINTX Technologies had a gross margin of 27.82% for the quarter that ended in Mar. 2024 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


SINTX Technologies Gross Margin % Related Terms

Thank you for viewing the detailed overview of SINTX Technologies's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


SINTX Technologies (FRA:1110) Business Description

Traded in Other Exchanges
Address
1885 West 2100 South, Salt Lake City, UT, USA, 84119
SINTX Technologies Inc is a commercial biomaterial company engaged in using its silicon nitride technology platform to develop, manufacture, and sell a range of medical devices. The company derives product revenue primarily from the manufacture and sale of spinal fusion products used in the treatment of spine disorders. It produces silicon nitride for use in commercial products and product candidates in the forms of Solid Silicon Nitride, Porous Silicon Nitride, and Silicon Nitride Powder, among others. It is also engaged in developing wear-and corrosion-resistant implant components for hip and knee arthroplasty.

SINTX Technologies (FRA:1110) Headlines

No Headlines